You have 9 free searches left this month | for more free features.

Perioperative chemotherapy

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Colorectal Tumors Trial in Gent (perioperative chemo plus bevacizumab, cytoreductive surgery, Intraperitoneal Oxaliplatin)

Active, not recruiting
  • Colorectal Neoplasms
  • perioperative chemotherapy plus bevacizumab
  • +2 more
  • Gent, Belgium
    Ghent University Hospital
Dec 12, 2022

Gastric Cancer Trial in Mykolaiv (Docetaxel, Oxaliplatin, Leucovorin)

Active, not recruiting
  • Gastric Cancer
  • Mykolaiv, Ukraine
    Ukrainian Society of Clinical Oncology
Apr 11, 2022

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Epstein-Barr Virus-Associated Gastric Carcinoma Trial

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • Hangzhou, Zhejiang, China
  • +7 more
Jul 25, 2023

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, HER2-positive Gastric Cancer Trial in China

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • Hangzhou, Zhejiang, China
  • +7 more
Feb 7, 2023

Esophageal Squamous Cell Carcinoma Trial in Shanghai (Sintilimab, Chemotherapy)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 30, 2023

Gastroesophageal Junction Adenocarcinoma, Stomach Tumors Trial in Barcelona (Avelumab addition to perioperative chemo in GC and

Recruiting
  • Gastroesophageal Junction Adenocarcinoma
  • Stomach Neoplasms
  • Avelumab addition to perioperative chemotherapy in GC and GEJC
  • Barcelona, Spain
    Vall d'Hebron Institute of Oncology
Oct 11, 2022

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Proficient Mismatch Repair Trial in China (S1,

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • Hangzhou, Zhejiang, China
  • +4 more
May 23, 2023

Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy, Adjuvant Therapy Trial in Shanghai (Tislelizumab)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai chest hospital
Sep 24, 2023

Gastric Cancer Trial in Xi'an (Penpulimab combined with Anlotinib Hydrochloride Capsules and chemo;Cadonilimab combined with

Not yet recruiting
  • Gastric Cancer
  • Penpulimab combined with Anlotinib Hydrochloride Capsules and chemotherapy;Cadonilimab combined with Anlotinib Hydrochloride Capsules and chemotherapy
  • Xi'an, Shaanxi, China
    The First Affiliated Hospital of Air Force Military Medical Univ
Mar 23, 2023

Gastric Cancer Trial in Krakow (FLOT4 + HIPEC + Surgery, FLOT4 + Surgery)

Recruiting
  • Gastric Cancer
  • FLOT + HIPEC + Surgery
  • FLOT + Surgery
  • Krakow, Lesser Poland Voivodship, Poland
    Department of General, Oncological, Gastroenterological Surgery
Nov 9, 2022

MSI-H Colorectal Cancer, Tislelizumab, Oxaliplatin Trial (Tislelizumab)

Not yet recruiting
  • MSI-H Colorectal Cancer
  • +3 more
  • (no location specified)
Apr 23, 2023

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Mismatch Repair Deficiency Trial in China

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • Hangzhou, Zhejiang, China
  • +7 more
Feb 7, 2023

Pancreatic Ductal Adenocarcinoma, Oligometastatic Disease Trial in Baltimore (FOLFIRINOX chemo)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Oligometastatic Disease
  • FOLFIRINOX chemotherapy
  • Baltimore, Maryland
    Johns Hopkins Hospital
Nov 2, 2023

Gastric Cancer, Gastric Adenocarcinoma, Effects of Chemo Trial in Taiwan (leucovorin, oxaliplatin, docetaxel, S-1)

Recruiting
  • Gastric Cancer
  • +3 more
  • leucovorin, oxaliplatin, docetaxel, S-1
  • Kaohsiung, Taiwan
  • +3 more
May 24, 2022

COMPARATIVE EFFECTS OF PERIOPERATIVE AND ADJUVANT CHEMOTHERAPY

Completed
  • Gastric Cancer, Outcomes, Pakistan, Adjuvant Chemotherapy, Perioperative Chemotherapy
    • (no location specified)
    Aug 3, 2021

    Stomach Cancer Trial (Tirelizumab, Trastuzumab, Docetaxel)

    Not yet recruiting
    • Stomach Cancer
    • (no location specified)
    Aug 19, 2021

    Esophageal Adenocarcinoma (UICC TNM7), Adenocarcinoma of the Esophagogastric Junction Trial in Germany (5-Fluorouracil,

    Active, not recruiting
    • Esophageal Adenocarcinoma (UICC TNM7)
    • Adenocarcinoma of the Esophagogastric Junction
    • Aachen, Germany
    • +29 more
    Nov 1, 2022

    Hepatocellular Carcinoma Trial in Guangzhou (Sintilimab)

    Recruiting
    • Hepatocellular Carcinoma
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Sep 4, 2023

    Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Houston (Fluorouracil, Leucovorin, Oxaliplatin)

    Not yet recruiting
    • Gastric Adenocarcinoma
    • Gastroesophageal Junction Adenocarcinoma
    • Houston, Texas
    • +3 more
    Nov 13, 2022

    Gastric Cancer Trial (Penpulimab combination with anlotinib and chemo)

    Not yet recruiting
    • Gastric Cancer
    • Penpulimab combination with anlotinib and chemotherapy
    • (no location specified)
    May 17, 2022

    Urothelial Bladder Carcinoma Trial in Spain (Sacituzumab govitecan, Zimberelimab, Domvanalimab)

    Not yet recruiting
    • Urothelial Bladder Carcinoma
    • Sacituzumab govitecan
    • +2 more
    • Santiago De Compostela, A Coruña, Spain
    • +9 more
    Nov 14, 2023

    Immunotherapy, Analgesia, NSCLC Trial in Tianjin (neoadjuvant immunotherapy, Neoadjuvant chemo)

    Recruiting
    • Immunotherapy
    • +3 more
    • neoadjuvant immunotherapy
    • Neoadjuvant chemotherapy
    • Tianjin, Tianjin, China
    • +2 more
    Aug 23, 2022

    Locally Advanced Rectal Cancer Trial in Shanghai (SHR-1701;Capecitabine;Oxaliplatin)

    Recruiting
    • Locally Advanced Rectal Cancer
    • Shanghai, Shanghai, China
      Fudan University Zhongshan Hospital
    Jul 26, 2022

    An Audit of Cytoreductive Surgery and Hyperthermic

    Recruiting
    • Colorectal Cancer
    • +2 more
    • Hyperthermic intraperitoneal chemotherapy
    • Mumbai, Maharashtra, India
      Tata Memorial Hospital
    Apr 25, 2022

    Metastatic Colorectal Cancer Trial in United States (mFOLFOX6, MVA-BN-CV301, FPV-CV301)

    Active, not recruiting
    • Metastatic Colorectal Cancer
    • Duarte, California
    • +6 more
    Jan 18, 2023